Effect of Multisensory Stimulation on Pain During Heel Lance in Newborns
Condition(s) studied
Investigational drug(s) / intervention(s)
Multisensory Stimulation: The multisensory stimulation intervention consists of four components: breastfeeding, gentle stroking, maternal singing or lullaby, and eye contact. Breastfeeding will begin 10 minutes before heel blood sampling and continue until 5 minutes after the procedure. During the same 15-minute period, the mother will gently stroke the newborn's leg from which the heel blood sample will be obtained. Throughout the heel blood sampling procedure, the mother will sing a lullaby or song in a soft and calm voice and maintain continuous eye contact with the newborn. No standardized song or lullaby will be prescribed, and the sound level will remain within the range of natural mother-newborn communication.
Study summary
This randomized controlled study will evaluate whether multisensory stimulation can reduce pain in healthy newborns during heel blood sampling. Newborns will be assigned to either a multisensory stimulation group, which includes breastfeeding, gentle stroking, maternal singing, and eye contact, or a control group in which the procedure will be performed while the newborn is held in the mother's arms. Pain scores, crying duration, heart rate, oxygen saturation, and procedure duration will be compared between the groups.
Eligibility
Primary outcome measure(s)
- N-PASS Pain Score — Immediately before, during, and immediately after heel blood sampling.
Newborn pain will be assessed using the Neonatal Pain, Agitation and Sedation Scale (N-PASS). The scale evaluates crying or irritability, behavioral state, facial expression, extremity tone or body tension, and changes in vital signs. Higher pain scores indicate greater pain or agitation.
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Tatvan State Hospital | Ankara | Beşevler | Recruiting |
| Bitlis State Hospita | Bitlis | Bitlis | Recruiting |
More Baskent University trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07747649 on ClinicalTrials.gov ↗ ← All trials in Turkey